Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes

NCT01084005 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: linagliptin
DRUG: placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]